| Asia's ascent—global trends in biomedical R&D expenditures J Chakma, GH Sun, JD Steinberg, SM Sammut, R Jagsi New England Journal of Medicine 370 (1), 3-6, 2014 | 171 | 2014 |
| Indian vaccine innovation: the case of Shantha Biotechnics J Chakma, H Masum, K Perampaladas, J Heys, PA Singer Globalization and health 7, 1-10, 2011 | 35 | 2011 |
| Life sciences venture capital in emerging markets J Chakma, SM Sammut, A Agrawal Nature Biotechnology 31 (3), 195-201, 2013 | 29 | 2013 |
| Can incubators work in Africa? Acorn Technologies and the entrepreneur-centric model J Chakma, H Masum, PA Singer BMC international health and human rights 10, 1-8, 2010 | 26 | 2010 |
| Turning science into health solutions: KEMRI’s challenges as Kenya’s health product pathfinder K Simiyu, H Masum, J Chakma, PA Singer BMC International Health and Human Rights 10, 1-9, 2010 | 18 | 2010 |
| Is it virtuous to be virtual? The VC viewpoint J Chakma, JL Calcagno, A Behbahani, S Mojtahedian Nature Biotechnology 27 (10), 886-888, 2009 | 17 | 2009 |
| Catalyzing capital for Canada's life sciences industry J Tucker, J Chakma, PWM Fedak, M Cimini Journal of Commercial Biotechnology 17, 330-348, 2011 | 14 | 2011 |
| Global biomedical R&D expenditures AJ Young, RF Terry, JA Rottingen, RF Viergever | 12 | 2014 |
| Venture funding for science-based African health innovation H Masum, J Chakma, K Simiyu, W Ronoh, AS Daar, PA Singer BMC International Health and Human Rights 10, 1-10, 2010 | 11 | 2010 |
| India's billion dollar biotech J Chakma, H Masum, K Perampaladas, J Heys, PA Singer Nature Biotechnology 28 (8), 783-783, 2010 | 11 | 2010 |
| Market minded development H Batavia, J Chakma, H Masum, P Singer Stanford Social Innovation Review 9 (1), 66-71, 2011 | 9 | 2011 |
| Biotechnology and global health. H Masum, J Chakma, AS Daar Global health and global health ethics, 251-260, 2011 | 3 | 2011 |
| Developing countries can contribute to global health innovation J Chakma, H Chakma Nature Medicine 19 (2), 129-129, 2013 | 2 | 2013 |
| Avoiding capital punishment J Chakma, E Forster, TE Hughes Bioentrepreneur, 1-3, 2010 | 2 | 2010 |
| Back to first principles J Chakma Nature 460 (7256), 769-769, 2009 | 2 | 2009 |
| Innovation: venture capital is vital too J Chakma, SM Sammut Nature 469 (7330), 299-299, 2011 | 1 | 2011 |
| Science-savvy physicians J Chakma Science 325 (5945), 1204-1205, 2009 | 1 | 2009 |
| Educate physicians about investor types J Chakma Nature 494 (7437), 314-314, 2013 | | 2013 |
| In Defense of Physician-Investor Collaboration J Chakma Science 339 (6121), 756-757, 2013 | | 2013 |
| Healthcare Venture Capital for Africa J Chakma, SM Sammut Science 331 (6017), 532-533, 2011 | | 2011 |
